SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BDR who wrote (3440)7/16/1999 8:13:00 AM
From: BMcV  Read Replies (1) of 10280
 
>>I do, but that pipeline didn't keep the price from dropping from $140 to $60. That seems like more than just the usual correction. What is different about this run up that will make it more sustainable?<<

A 50% correction in a "story stock" (ie one that has no operating results yet) is normal and predictable. And that 140 high is also a little suspect, since is occurred on a one day spike, up something like 13 points.

What will make this rise more sustainable? The correction.

Let's not forget where we've come from. A year ago we were just pushing 50 for the first time ever. Now we have proven there is rock-solid support at 60. We're up 50% from the low, halfway between the low and the 120-125 range. And doesn't it seem like a long time since we're had good news out of the company?

Only hurdle is the actual sales figures for Xopenex with this quarter's results. They should be good because of shelf-stocking, but you never know.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext